Immunomic Therapeutics' CEO to present at the 13th Annual Biotech Showcase Digital Event
Immunomic Therapeutics’ CEO to present at the 13th Annual Biotech Showcase Digital Event Immunomic Therapeutics’ CEO to present at the 13th Annual Biotech Showcase Digital Event Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the 13 th Annual Biotech Showcase Digital Event, January 11-15, 2021. Chief Executive Officer at ITI, Dr. Bill Hearl, will present a talk titled, ITI-1000-A Novel Immunotherapy for GBM. Dr. Hearl will discuss ITIs investigational UNiversal Intracellular Targeted Expression (...
Source: globalbankingandfinance.com